Introduction {#s1}
============

The development of a fertilized egg is initially under the control of maternal products and then becomes under zygotic control when transcription begins. In animals such as *Xenopus*, zebrafish and *Drosophila*, development begins with rapid, synchronous cell divisions without gap phases ([@bib27]; [@bib40]; [@bib54]). During the midblastula transition (MBT), cells switch to prolonged asynchronous divisions and this coincides with a massive increase in zygotic transcription. Before the MBT, only a small set of 'pre-MBT genes' are expressed. How this differential transcription is set up globally during these early stages of development, including the role of histone modifications and the recruitment of RNA Polymerase II (Pol II), has been the subject of considerable interest ([@bib2]; [@bib60]; [@bib35]). In mammalian embryonic stem cells, as well as early *Drosophila* embryos, paused Pol II is frequently found at developmental control genes ([@bib20]; [@bib63]; [@bib38]), but it is not known when pausing is first established in the embryo. Pol II pausing prior to activation may promote the rapid and synchronous induction of genes ([@bib8]; [@bib1]), but it is unclear whether Pol II can be recruited and paused during the rapid early nuclear cycles prior to the MBT ([@bib26]; [@bib42]).

Results {#s2}
=======

Massive de novo Pol II recruitment during the midblastula transition {#s2-1}
--------------------------------------------------------------------

We first probed the status of Pol II in the early embryo by immunostainings ([Figure 1A](#fig1){ref-type="fig"}). In *Drosophila*, the MBT mainly occurs in the interphase of nuclear cycle 14, just before cellularization and subsequent gastrulation ([@bib16]), although there is some evidence that this may already occur in nuclear cycle 13 ([@bib22]). Before the MBT, a small fraction of genes ([@bib11]; [@bib55]) may be transcribed as early as nuclear cycle 8.10.7554/eLife.00861.003Figure 1.Global recruitment of Pol II during the Drosophila midblastula transition.(**A**) Immunostainings of embryos during pre-blastoderm stages (nc 1--7), pre-MBT (nc 8--12) and MBT (nc 13--14) suggest that the initiated form of Pol II (serine-5-phosphorylation of the CTD repeats---Ser5-P), as well as TBP are only detectible in the nuclei (outlined by the Lam 0 in red) of pre-MBT embryos when zygotic transcription begins (scale = 20 μm). (**B**) Outline of the hand-sorting of embryo collections for ChIP-Seq experiments. (**C**) Heat map of ChIP-seq enrichments across all genes that are significantly bound by Pol II during MBT. Pre-MBT genes are also significantly bound in the pre-MBT sample; MBT-maternal genes also have maternally provided transcripts in the early embryo (RPKM \> 1 during nc 10); the remaining genes are MBT-zygotic genes. Among the latter group, MBT active genes are expressed during the MBT (RPKM \> 5 at nc 14D), while the transcript levels of MBT poised genes are below this threshold. Each line shows the normalized enrichments for a gene from −200 bp to +800 bp from the TSS. Note that Pol II is only bound to few pre-MBT genes before the MBT and that there is massive de novo recruitment of Pol II during the MBT. AED = after egg deposition, nc = nuclear cycle.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.003](10.7554/eLife.00861.003)10.7554/eLife.00861.004Figure 1---figure supplement 1.Standards for staging pre-MBT and MBT embryos.Embryos from a pre-MBT collection (1--2 hr) were screened for embryos in nuclear cycle 13--14 or later and removed. Using DIC, these embryos were recognized by the cellularization or gastrulation furrow (marked by arrows in the post-MBT embryos), were removed. Under UV light, these embryos were recognized based on their number of nuclei with DAPI staining. Likewise, for MBT collections (2--3 hr), embryos with visible furrow formation or high DAPI staining were removed. The small number of embryos that were younger than the desired nuclear cycles were tolerated in both pre-MBT and MBT collections since they do not contribute a significant fraction of nuclei.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.004](10.7554/eLife.00861.004)10.7554/eLife.00861.005Figure 1---figure supplement 2.High reproducibility of pre-MBT and MBT Pol II ChIP-seq data and agreement with previous mRNA data.(**A**) Scatterplot comparing two pre-MBT Pol II and two MBT Pol II replicates. For each replicate, the enrichment over background in each TSS region (first 200 bp) is displayed. Genes that qualified as pre-MBT genes or MBT genes based on all replicates are shown in red. (**B**) Pearson correlations between all Pol II ChIP replicates in pre-MBT and MBT embryos. The TSS read counts from each Pol II replicate (numbered from r1 to r4) are compared with each other and with the input (starting material for the ChIP) for each stage. Note that the replicates have high correlations with each other, which far exceed the correlation with the input. (**C**) Venn diagram showing the strong overlap between pre-MBT active genes (those in the 'dual' and 'not paused' group) and early zygotic genes identified previously by mRNA microrarray analysis by Wieschaus et al. ([@bib11]).**DOI:** [http://dx.doi.org/10.7554/eLife.00861.005](10.7554/eLife.00861.005)10.7554/eLife.00861.006Figure 1---figure supplement 3.ChIP-seq occupancy of Pol II and TBP at pre-MBT genes with complex patterns. The reads were normalized to the total read count.(**A**) *MED11*, shown in red, is an example of a false pre-MBT gene due to read-through signal from an upstream gene, *CG6885*. (**B**) *CG11929*, shown in red, is an example of a false pre-MBT gene due to signal from an overlapping gene, *Bsg25A*. (**C**) *Taf4* has an un-annotated more proximal TSS (light grey) that is used during the pre-MBT stage. The two distal known TSSs are used during MBT. (**D**) *hb*, a pre-MBT dual gene has two known alternative TSSs that are differentially used during early development. While the most proximal TSS is preferentially used in pre-MBT and MBT embryos, the distal TSS is used mostly in the post-MBT stage.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.006](10.7554/eLife.00861.006)10.7554/eLife.00861.007Figure 1---figure supplement 4.Pre-MBT genes identified by ChIP-Seq show high conservation scores among insect genomes.Boxplot comparing conservation scores between gene groups. Each transcript's score is the mean of the phastCons scores (<http://genome.cshlp.org/content/15/8/1034>) along its annotated location from Flybase.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.007](10.7554/eLife.00861.007)

Our immunostainings show that unphosphorylated Pol II can be detected in nuclei from the earliest cleavage stages on, thus before the beginning of transcription. However, both TATA-box binding protein (TBP), the key subunit of TFIID, which binds to the promoter prior to Pol II recruitment, as well as Serine 5-phosphorylation of the C-terminal domain of Pol II (Ser5-P Pol II), which marks transcriptional initiation, can only be first detected during nuclear cycles 8--12, when significant transcription of pre-MBT genes occurs. This was the first indication that Pol II is recruited to promoters de novo during the zygotic genome activation.

We next performed chromatin immunoprecipitation experiments coupled to deep sequencing (ChIP-seq) to analyze the occupancy of Pol II, TBP and histone modifications in pre-MBT embryos (nuclear cycles 8--12), MBT embryos (nuclear cycles 13--14), as well as post-MBT embryos as control ([Figure 1B](#fig1){ref-type="fig"}). Although the large amount of *Drosophila* embryos required for ChIP-seq can be collected by conventional means, such collections always contain a fraction (5--20%) of older embryos due to maternal egg holding and thus cannot be used to study very early stages of embryogenesis ([@bib22]). To eliminate this contamination, we stained our embryo collections with DAPI and removed 'out-of-stage' embryos under a microscope with a pipette ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, and see 'Materials and methods').

The ChIP-seq data from these hand-sorted embryos have robust and reproducible signals in replicates ([Figure 1---figure supplement 2A,B](#fig1s2){ref-type="fig"}). Despite the high Pol II signal in the pre-MBT sample, Pol II only occupies around a hundred genes before the MBT ([Figure 1C](#fig1){ref-type="fig"}, [Supplementary file hosted by Dryad](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) \[7.6 Mb; [@bib10]\]). These genes include previously described pre-MBT genes, as defined by in situ hybridization ([@bib55]) and microarray data ([@bib11]) ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). In contrast, Pol II and TBP are recruited de novo to 4007 promoters during the MBT, which equates to roughly a third of all genes ([Figure 1C](#fig1){ref-type="fig"}, [Supplementary file hosted by Dryad](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) \[7.6 Mb\]). This shows that there is massive de novo recruitment of Pol II during the MBT.

No apparent Pol II pausing at the earliest transcribed genes {#s2-2}
------------------------------------------------------------

To obtain a complete list of pre-MBT genes occupied by Pol II before the MBT, we identified all genes with at least twofold enrichment of Pol II over input at the transcription start site across four Pol II ChIP-seq replicates. From this list, we removed 12 genes that were likely false positives as a result of Pol II read-through from a nearby gene and added 10 genes that were missed due to un-annotated alternative start sites (examples in [Figure 1---figure supplement 3A,B,C](#fig1s3){ref-type="fig"}). This yielded 117 pre-MBT genes, many of which have known functions in sex determination, cellularization, anterio-posterior patterning and dorso-ventral patterning ([Table 1](#tbl1){ref-type="table"}). Among them are also 14 precursors of non-coding RNAs, which are involved in maternal RNA degradation, dosage compensation, and RNA splicing, as well as many genes whose function is unknown but that are well conserved among insect species ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}, [Supplementary file hosted by Dryad](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) \[7.6 Mb\]).10.7554/eLife.00861.008Table 1.Classification of pre-MBT genes**DOI:** [http://dx.doi.org/10.7554/eLife.00861.008](10.7554/eLife.00861.008)FunctionGene namesSex determination**Dpn**, sisA, Sxl, osCellularizationnullo, Sry-alpha, kuk, bnk, slamAnterio-posterior patterningcad, hb, gt, kni, tll, eve, h, run, slp1, odd, ftz, *Egfr*Dorso-ventral patterning**sna**, **esg**, **Nrt**, **glec**, **ac**, **l(1)sc**, **Tom**, **BobA**, **m4**, zen, zen2, tsg, tld, scw, Neu2, sc, fd19B, bnb, Bro, Brd, Ocho, amos, ato, *sim*, *lea*Other function**Taf4**, **wech**, **Corp**, **toc**, **spri**, Z600, halo, SNCF, CG4570, spo, hrg, *sca*, *Lac*, *RpL3*, *btsz*, *αTub84B*Non-coding RNAmir-9a, mir-309, roX1, snRNA:U5:34A, snRNA:U4atac:82E, snRNA:U1:82 Eb, snRNA:U5:23D, snRNA:U5:38ABb, snRNA:U5:14B, snRNA:U4:38AB, snRNA:U1:95CcUnknown function Localized expression**gk**, **CG9894**, **CG5059**, sala, term, CG14427, CG8960, CG13711, CG13713, CG15876, CG6885, CG7271, CG14014 Ubiquitous expressionBsg25A, Bsg25D, CG15634, CG15382 Others**CG2201**, **CG42666**, CG43659, CG13716, CG13712, CG13000, CG13465, CG14561, CG18269, CG14915, CG16813, CG15479, CG15480, CG4440, CG14317, CG13427, CG34137, CG34214, CG34224, CG34266, CG16815, CG42762, CG43184, CG 9775, CG9883, CR43887, *CG9821*, *CG33232*[^1]

Inspection of the Pol II occupancy revealed that most pre-MBT genes have no notable enrichment of Pol II at the pause site (+30--50 bp downstream from the transcription start site \[[@bib63]\]) when they are initially transcribed, while TBP occupancy is found upstream (on average −20 bp from the transcription start site) ([Figure 2](#fig2){ref-type="fig"}). When quantifying the degree of pausing with the pausing index (see 'Materials and methods'), pre-MBT genes are indeed much less paused than MBT genes ([Figure 2A](#fig2){ref-type="fig"}). However, a small number of pre-MBT genes have a higher pausing index, lack enrichment of Pol II within the gene body and thus may be paused.10.7554/eLife.00861.009Figure 2.Minimal Pol II pausing before the MBT.(**A**) Violin plot of the Pol II pausing index distribution shows that pre-MBT genes (during pre-MBT stages) display less Pol II pausing than MBT genes (during the MBT stage). The width of a violin plot is equivalent to a density curve showing the distribution of values (here pausing indices) within a dataset. (**B**) Median RNA-seq expression data ([@bib36]) of the three pre-MBT groups and the two MBT groups shows that paused genes are expressed at lower levels and tend to be induced later. (**C**) Examples and average enrichment of Pol II occupancy (blue) and TBP occupancy (pink) for the three pre-MBT gene groups. Examples are shown as normalized reads while average enrichment is normalized to input. Note that pre-MBT not-paused genes have a non-paused Pol II profile since they do not show elevated Pol II levels at the pause site during pre-MBT and MBT stages. Pre-MBT dual genes switch from an initial non-paused profile during pre-MBT stages to a paused profile during the MBT. Pre-MBT paused genes appear to be paused even during pre-MBT stages. AED = after egg deposition, nc = nuclear cycle.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.009](10.7554/eLife.00861.009)

We then classified the pre-MBT genes based on their Pol II occupancy during development and identified three distinct groups ([Figure 2B,C](#fig2){ref-type="fig"}, [Supplementary file hosted by Dryad](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) \[7.6 Mb\]). Genes in the first group ('pre-MBT not-paused', n = 77) have highest expression during cellularization (nuclear cycle 14) and tend to diminish in expression thereafter ([Figure 2B](#fig2){ref-type="fig"}). These genes appear never to become paused during early development (see *SNCF* and the average profile in [Figure 2C](#fig2){ref-type="fig"}). Genes in the second group ('pre-MBT dual', n = 30) initially show little evidence of pausing; however, higher levels of Pol II gradually accumulate at the pause site during and after the MBT (see *ac* and the average profile in [Figure 2C](#fig2){ref-type="fig"}). Finally, there is a small group of genes ('pre-MBT paused', n = 10) that appear to have Pol II that is paused or non-productive even at the pre-MBT stages (see *sim* and the average profile in [Figure 2C](#fig2){ref-type="fig"}). This is consistent with the expression of these genes; their transcript levels rise much later during pre-MBT stages as compared to the first two groups ([Figure 2B](#fig2){ref-type="fig"}). This suggests that Pol II pausing exists during pre-MBT stages but that most genes are non-paused.

As a control, we analyzed Pol II pausing at genes that are newly occupied by Pol II during the MBT ('MBT genes', [Supplementary file hosted by Dryad](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) \[7.6 Mb\]). We first subtracted from them the 3163 genes that are also maternally expressed ('MBT-maternal genes') because they are known to be enriched for broadly expressed housekeeping genes ([@bib45]). The remaining 844 genes ('MBT-zygotic genes') frequently have high Pol II occupancy at the pausing site and a high pausing index ([Figure 3](#fig3){ref-type="fig"}), suggesting that Pol II pausing is widespread during the MBT.10.7554/eLife.00861.010Figure 3.Widespread Pol II pausing of MBT genes and poising for later activation.(**A**) Examples and average normalized enrichment (as in [Figure 2C](#fig2){ref-type="fig"}) of Pol II occupancy (blue) and TBP occupancy (pink) for the MBT-zygotic genes that are significantly transcribed during MBT (MBT active) or not (MBT poised). Both groups show widespread Pol II pausing. (**B**) Analysis of large scale in situ hybridizations (ImaGO database, see 'Materials and methods') confirms the earlier initial expression of MBT active genes (mostly stage 4--6, peri-cellularization) and shows that many MBT poised genes are first transcribed at later stages of embryogenesis (mostly stage 9--10, post-gastrulation).**DOI:** [http://dx.doi.org/10.7554/eLife.00861.010](10.7554/eLife.00861.010)

When we analyzed the expression of these MBT-zygotic genes ([@bib36]), we found that 251 genes (30%) are expressed at significant levels during late nuclear cycle 14 ('MBT active genes', see *brk* and the average profile in [Figure 3A](#fig3){ref-type="fig"}), while the remaining 593 genes ('MBT poised genes', see *Dr* and the average profile in [Figure 3A](#fig3){ref-type="fig"}) are expressed at very low levels typical for paused genes poised for activation ([@bib63]; [@bib1]). This difference in expression was confirmed by analyzing their in situ hybridization patterns: while the MBT active genes are expressed very early, the MBT poised genes tend to be first detected at later embryonic stages (stages 9--10 or later) ([Figure 3B](#fig3){ref-type="fig"}). Thus, many genes become newly paused during the MBT and are poised for later activation.

The significant difference seen in Pol II pausing between pre-MBT and MBT genes is likely to be biologically meaningful. Genes expressed before the MBT have to be transcribed particularly fast because the nuclear cycle is extremely short (8 min in nuclear cycle 10, increasing to 13 min in nuclear cycle 12 \[[@bib16]\]) and progression through mitosis causes abortion of nascent transcripts ([@bib47]; [@bib50]). As previously noted ([@bib11]), we also found that the pre-MBT genes are particularly short (median of 1228 bp vs 6024 bp, Mann--Whitney test p\<10^−20^) and more often intronless (54.6% vs 9.2%, Fisher test p\<10^−23^) compared to MBT-zygotic genes. We also noticed that pre-MBT genes frequently use the transcription start site that yields the shortest transcript (62.9% vs 30.6%, Fisher test p\<0.0003) ([Table 2](#tbl2){ref-type="table"}, and examples in [Figure 1---figure supplement 3C,D](#fig1s3){ref-type="fig"}). This supports the idea that rapid transcription is important during the fast cleavage cycles before the MBT and makes it plausible that the lack of Pol II pausing is advantageous for pre-MBT transcription.10.7554/eLife.00861.011Table 2.Size and intron difference between pre-MBT and MBT zygotic genes**DOI:** [http://dx.doi.org/10.7554/eLife.00861.011](10.7554/eLife.00861.011)Transcript sizeShortest transcript usageIntron contentGene groupGene countMedian width (bp)Genes with multiple TSSGenes using shortest transcript (%)Gene count (protein-coding)Genes with no introns (%)All pre-MBT1171228[\*](#tblfn1){ref-type="table-fn"}3522 (62.9%)[†](#tblfn2){ref-type="table-fn"}9753 (54.6%)[‡](#tblfn3){ref-type="table-fn"}MBT maternal316333221125308 (27.4%)3163228 (7.2%)MBT zygotic844604228487 (30.6%)73668 (9.2%) active251542219150 (26.2%)25135 (13.9%) poised59367719337 (39.8%)48533 (6.8%)[^2][^3][^4]

Absence of H3K27me3 and H3K4me3 before transcription {#s2-3}
----------------------------------------------------

We next explored potential mechanisms that could explain the difference between pre-MBT and MBT genes. Histone modifications such as H3K4me3 and H3K27me3 are present in embryonic stem cells ([@bib7]), in human sperm ([@bib21]), and may be present in zebrafish embryos before gene activation ([@bib60]; [@bib35]). However, we did not find these marks in *Drosophila* nuclei prior to gene activation. In both immunostainings and ChIP-seq data, the signal of H3K4me3, a modification associated with gene activation, only starts to be detectable during the MBT ([Figure 4A](#fig4){ref-type="fig"}, see also the ChIP-seq results in [Figure 1C](#fig1){ref-type="fig"}). H3K27me3, a marker of Polycomb-mediated gene silencing and possibly epigenetic memory, can be detected in nuclei and in polar bodies at the earliest cleavage stages but is then undetectable in somatic nuclei until after the MBT ([Figure 4C](#fig4){ref-type="fig"}). Consistent with this, the ChIP-seq H3k27me3 signal at Polycomb response elements (PREs) increases over time ([Figure 4B](#fig4){ref-type="fig"}). Thus, H3K27me3 is likely present in oocytes but may be diluted or erased during replication consistent with a recent study ([@bib42]). Accordingly, it seems unlikely that H3K4me3 or H3K27me27 have a direct role in regulating the zygotic genome activation in *Drosophila*.10.7554/eLife.00861.012Figure 4.Absence of bivalent domains in pre-MBT embryos.(**A**) Lack of detectable H3K4me3 immunostaining in nuclei of embryos before MBT. H3K27me3 is observed in nuclei and polar bodies (pb) of early pre-blastoderm nuclei but not during pre-MBT or MBT stages. H3K27me3 first becomes detectable again in post-MBT embryos (scale = 20 μm). (**B**) ChIP-seq experiments also suggest that H3K27me3 is absent during the MBT but that the levels increase soon after. Shown is the average pattern of H3K27me3 signal over input surrounding 441 previously identified Polycomb response elements (PREs). (**C**) Despite high levels of Pol II occupancy, H3K4me3 average gene enrichments are low at pre-MBT genes (top left). This is in contrast to MBT-maternal genes, which have high H3K4me3 enrichment that peaks ∼200 bp downstream of the TSS (bottom left). All enrichments are calculated over input and normalized (see 'Materials and methods'). The overall nucleosome occupancy, as measured by MNase digestion, shows more pronounced nucleosome positioning at MBT maternal genes but the overall nucleosome occupancy is not dramatically different (compare top and bottom panels at the right). Average read counts from a Micrococcal Nuclease (MNase) experiment are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.012](10.7554/eLife.00861.012)

We also noticed that pre-MBT genes tend to have particularly low levels of H3K4me3 ([Figure 4C](#fig4){ref-type="fig"}). Even when pre-MBT genes continue to be transcribed during the MBT, H3K4me3 tends to be low and to accumulate to highest levels at further downstream nucleosomes at pre-MBT genes. This is in stark contrast to the MBT-maternal group, which has a sharp peak of H3K4me3 at the +1 nucleosome. This difference cannot be explained by lower levels of nucleosomes since the nucleosome occupancy based on our Micrococcal Nuclease experiments coupled to deep sequencing (MNase-seq) does not show a dramatic difference between the two gene groups ([Figure 4C](#fig4){ref-type="fig"}). Since histone modification levels tend to be dependent on the promoter types ([@bib44]), we next analyzed whether pre-MBT genes are enriched for specific core promoter elements.

The different Pol II profiles correlate with distinct promoter types {#s2-4}
--------------------------------------------------------------------

We analyzed well-studied sequence motifs associated with either focused or dispersed transcription initiation in *Drosophila* ([Table 3](#tbl3){ref-type="table"}). Focused transcription initiates within a very narrow window and often at a single nucleotide (also called peaked promoters), while dispersed transcription initiates from several weak transcription start sites within a ∼50--100 nucleotide region (also called broad promoters) ([@bib25]). In *Drosophila*, dispersed initiation is typically found at broadly expressed housekeeping genes with constitutive promoters. Consistently, we found that MBT-maternal genes are strongly enriched for core promoter elements associated with dispersed initiation: Ohler1, Ohler6, Ohler7 and Dref response element (DRE) ([Figure 5A](#fig5){ref-type="fig"}). Core promoter elements associated with focused initiation such as Initiator (Inr), downstream promoter element (DPE), Motif Two Element (MTE) and Pause Button (PB) have previously been associated with paused genes ([@bib23]; [@bib29]). As expected, MBT-zygotic genes are highly enriched for these elements, as well as GAGA, which is consistent with reports that GAGA factor (GAF) promotes the recruitment of paused Pol II ([@bib30]; [@bib31]; [@bib29]). We noticed that these genes are not significantly enriched for the TATA box, although they are usually occupied by TBP ([Figure 1C](#fig1){ref-type="fig"}, and [Figure 3A](#fig3){ref-type="fig"}).10.7554/eLife.00861.013Table 3.*Drosophila* promoter elements analyzed in this study**DOI:** [http://dx.doi.org/10.7554/eLife.00861.013](10.7554/eLife.00861.013)Motif nameIUPAC consensusDirectionalWindow (bp from TSS)Transcript countReferenceNoteDREWATCGATWYes−100 to 02111([@bib24])Dispersed initiationOhler1YGGTCACACTRYes−100 to 50609([@bib41])Ohler6YRGTATWTTYYes−150 to 25840([@bib41])Ohler7CAKCNCTRYes−100 to 502190([@bib41])TATASTATAWAWRYes−100 to 01503([@bib18])Focused initiationInrTCAKTYYes−50 to 505965([@bib52])DPEKCGGTTSKYes0 to 75537([@bib9])PBKCGRWCGYes−50 to 1002093([@bib23])MTECSARCSSAYes0 to 30212([@bib34])GAGAGAGANo−100 to 09559([@bib53])Other motifsZeldaYAGGTARNo−2000 to 09798([@bib33]; [@bib55])10.7554/eLife.00861.014Figure 5.Differential usage of core promoter elements during the zygotic genome activation.(**A**) Promoter analysis of all previously identified gene groups. Shown is the enrichment of known core promoter elements found in promoters with dispersed initiation or focused initiation, as well as in the binding motifs for GAGA factor (GAF) and Zelda. Only occurrences close to the known location of the motif relative to the TSS were scored (see [Table 3](#tbl3){ref-type="table"}). The star indicates significant enrichment (orange) or depletion (black). Note that the three pre-MBT groups with different Pol II pausing patterns are enriched for distinct core promoter elements. (**B**) The top two known motifs identified by de novo motif analysis for active pre-MBT genes and active MBT genes. The analysis was performed with MEME on the 200 bp long region centered on the TSS. The number of occurrences, p-value and the density distributions relative to the TSS of the identified motifs are shown on the right. Note that all motifs are found with the highest frequency at the expected location but that the DPE/MTE/PB is less specific and more frequently found at positions where it is unlikely to be functional.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.014](10.7554/eLife.00861.014)10.7554/eLife.00861.015Figure 5---figure supplement 1.High frequency of Zelda motifs in the promoter region of pre-MBT genes.Histograms showing the distribution of the number of Zelda motifs found in each promoter region (2 kb upstream of the TSS, see 'Materials and methods') among all genes, all MBT genes, all pre-MBT genes, and MBT active genes. Pre-MBT genes are significantly enriched for Zelda motifs (p\<0.005). MBT active genes may also show a small enrichment (p\<0.1).**DOI:** [http://dx.doi.org/10.7554/eLife.00861.015](10.7554/eLife.00861.015)10.7554/eLife.00861.016Figure 5---figure supplement 2.Analysis of the co-occurrence of promoter elements among all genes and early genes.The relative enrichment or depletion of the co-occurrences compared to the frequency expected by random chance is shown. Significant values (p\<0.05, Fisher test) are marked with a star. The order of the motifs is based on hierarchical clustering of the enrichment values shown in **C**. Groups of co-occurring motifs are highlighted in red. Our analysis for all genes produces similar results to those published previously by [@bib15]. The results from the FitzGerald analysis (which included 8,289 transcripts available at the time) are graphically visualized by our method (**A**). Our updated analysis using all current FlyBase promoters (19,845 transcripts) and additional motifs are shown in comparison (**B**). The co-occurrence of pausing elements (MTE, PB, DPE, Inr, GAGA) and dispersed promoter elements (DRE, Ohler7, Ohler1, Ohler6), respectively, are marked with a red box. Note that the motifs in the FitzGerald analysis deviate in some cases from our promoter elements (e.g., GAGA), which explains some differences. We then compared the results to our 'pre-MBT and MBT' set (**C**). The co-occurrence of TATA, Inr and Zelda (as well as with GAGA, which is found in dual genes) is significant in this set (marked with a red box), suggesting that promoters with this combination of motifs are preferentially found among early genes.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.016](10.7554/eLife.00861.016)

In contrast, the promoters of pre-MBT genes are significantly enriched for TATA ([Figure 5A](#fig5){ref-type="fig"}, [Supplementary file hosted by Dryad](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) \[7.6 Mb\]). Interestingly, only pre-MBT genes that initially show the non-paused profile (pre-MBT not-paused, pre-MBT dual) are significantly enriched for Inr and TATA. Furthermore, only pre-MBT genes that are paused at some point (pre-MBT dual, pre-MBT paused) show enrichment for GAGA, Inr and PB ([Figure 5A](#fig5){ref-type="fig"}). Thus, the presence of specific core promoter elements correlates well with the Pol II occupancy profile across the gene body.

Previous studies have shown that the transcription factor Zelda and its binding motif (known as the TAGteam motif) regulates the onset of zygotic gene expression ([@bib11]; [@bib22]; [@bib33]; [@bib55]). Notably, the binding levels of Zelda in the promoter region correlate well with the onset of gene expression, although Zelda is also abundantly found at enhancers ([@bib22]). Consistent with this, we found that Zelda motifs are highly enriched in the promoter region of pre-MBT genes ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). However, this enrichment is found in all three pre-MBT classes and does not correlate with the Pol II pausing pattern ([Figure 5A](#fig5){ref-type="fig"}).

To further consolidate the differences between pre-MBT and MBT genes, we performed de novo motif analysis with MEME on the 200 bp centered on the transcription start site ([Figure 5B](#fig5){ref-type="fig"}). For pre-MBT stage non-paused genes (pre-MBT not-paused, pre-MBT dual), the top two motifs were Zelda and TATA ([Figure 5B](#fig5){ref-type="fig"}). In contrast, the top two known motifs for the most comparable MBT group (MBT active genes, which are also early-expressed developmental genes), were GAGA and a motif that resembles DPE, MTE and PB ([Figure 5B](#fig5){ref-type="fig"}). This confirms that pre-MBT and MBT genes differ in their core promoter sequences.

Finally, an analysis of the co-occurrences of core promoter elements similar to previous analyses ([@bib15]) also supports our finding ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). For example, Zelda, Inr and TATA significantly co-occur among all our Pol II-bound genes (pre-MBT and MBT genes) but not among all annotated genes, suggesting that these motifs preferentially function together during early development.

This suggests a model in which rapid pre-MBT transcription without Pol II pausing is mediated by Zelda bound close to a TATA-enriched promoter ([Figure 6](#fig6){ref-type="fig"}). In contrast, paused Pol II is typically established through GAF during the MBT at promoters with pausing elements such as DPE, MTE or PB. Thus, there are two principle modes by which zygotic genes are activated but genes may also have elements of both and show a dual behavior.10.7554/eLife.00861.017Figure 6.Proposed model for the two main modes of Pol II recruitment and elongation behavior during the zygotic genome activation.Before the midblastula transition, when the cell cycle is fast, efficient transcription occurs through a TATA promoter with multiple Zelda sites upstream. This combination leads to transcription without pausing, presumably due to fast re-initiation. During the midblastula transition, Pol II is recruited de novo to many genes and pausing is established with the help of GAGA factor and core promoter elements associated with pausing such as DPE, MTE and PB. Note that genes can have core promoter elements of both modes (e.g., TATA and PB), leading them to switch from a non-pausing behavior to a pausing behavior during the midblastula transition. It is likely that transcription factors in addition to Zelda and GAF also influence the Pol II behavior at genes.**DOI:** [http://dx.doi.org/10.7554/eLife.00861.017](10.7554/eLife.00861.017)

Discussion {#s3}
==========

Our results suggest that a large number of genes first recruit Pol II during the MBT with widespread Pol II pausing, while the small number of genes transcribed before that are not paused. Presumably, these pre-MBT genes are required for very early developmental events such as sex determination ([@bib14]; [@bib6]) or cellularization ([@bib48]; [@bib43]), or may be involved in early patterning events that require feedback regulation over time (for example *ftz* \[[@bib13]; [@bib43]\] or *sna* \[[@bib12]; [@bib46]\]). Thus, while Pol II pausing is commonly found at developmental genes and may be advantageous for their precise and synchronous expression in response to localized extracellular signals ([@bib8]), a different mode of transcription is used during pre-MBT stages. Due to the short nuclear cycles at this stage, it is likely that transcription is optimized to achieve high levels of transcripts in a very short time period.

The fact that we find the TATA box enriched among pre-MBT genes is consistent with the known properties of TATA-containing promoters. TATA is a strong core promoter element that efficiently supports transcription in vitro ([@bib4]), mediates efficient re-initiation in vitro ([@bib61], [@bib62]), and its presence in vivo correlates with 'bursts' of transcription that produce many transcripts within a short time ([@bib64]). Furthermore, it has been shown that TATA promotes pTEFb activity, leading to more efficient elongation rates in vitro and in vivo ([@bib3]; [@bib39]).

This suggests that TATA-enriched promoters and paused promoters have different transcription dynamics and serve different purposes during development. While this difference is particularly evident during the zygotic genome activation as reported here, we propose that this difference is general and also applies to later development. For example, we have analyzed promoters during muscle development and find that many genes are induced during late stages of embryogenesis without prior Pol II pausing and that these genes are also enriched in TATA ([@bib17]). Consistent with this, statistical analyses suggest that the combination of Inr and TATA represents a separate class of promoters that is often found among genes expressed in adult tissues ([@bib15]; [@bib32]). Since the properties of TATA are not specific to *Drosophila*, it is likely that differences among promoter types and their propensity for Pol II pausing are conserved across animals.

Materials and methods {#s4}
=====================

Embryo collection and immunostainings {#s4-1}
-------------------------------------

Wild-type embryos (Oregon R) were collected from six population cages (28 × 17 × 17 cm, with 10,000--12,000 flies each, maintained in fly incubators at 25°C and 60% humidity) on 15 cm apple juice plates with yeast paste after pre-clearing. The collection windows were 0--4 hr after egg deposition (AED) for immunostainings, and 1--2 hr, 2--3 hr, 2--4 hr, 6--8 hr AED for ChIP. Embryos were dechorionated with bleach and cross-linked with 1.8% formaldehyde in 2.5 ml Hepes buffer and 7.5 ml heptane, while vortexing at medium speed for 15 min. Embryos were devitellinized in methanol/heptane and kept at −20°C in methanol for up to 3 months until needed. Immunostainings were performed by standard methods with Alexafluor Dyes and the embryos were analyzed by confocal imaging (Zeiss LSM-510-VIS, Carl Zeiss Microscopy, LLC, Thornwood, NY).

Antibodies {#s4-2}
----------

The following antibodies were used for immunostainings: mouse monoclonal antibody CTD4H8 against Pol II CTD (05-623; EMD-Millipore, Billerica, MA), mouse monoclonal antibody H14 against Ser5-phosophorylated Pol II (MMS-134R; Covance, Princeton, NJ), rabbit polyclonal antibodies against H3K4me3 (9751S; Cell Signaling Technology, Danvers, MA), rabbit polyclonal antibodies against H3K27me3 (39155; Active Motif, Carlsbad, CA), rabbit polyclonal antibodies against dTBP (a kind gift from J Kadonaga), and mouse monoclonal antibody against lamin 0 (ADL101 developed by P Fisher, obtained from the Developmental Studies Hybridoma Bank). Embryos were visualized by confocal imaging (LSM-510-VIS).

The following antibodies were used for ChIP: antibodies against dTBP (a kind gift from J Kadonaga), H3K4me3 (9751S; Cell Signaling Technology), H3K27me3 (39155; Active Motif), mouse monoclonal Pol II antibody 8WG16 (MMS-126R; Covance) and rabbit polyclonal antibodies against H3ac (07-360; Millipore).

Embryo sorting {#s4-3}
--------------

For embryo sorting, wild-type embryos collected within 1--2 hr (pre-MBT) and 2--3 hr (MBT) were fixed in 1.8% formaldehyde and stained with DAPI. Embryos were sorted in PBT on ice under an inverted contrasting microscope (Leica DMIL, Buffalo Grove, IL). All embryos were screened once for morphology with a DIC filter, and twice for DNA content under UV light ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Out-of-stage embryos were removed with a 10 μl pipette tip connected to a Cell Tram Vario (920002111; Eppendorf, Hauppauge, NY). After practice, 200 μl embryos (∼5000 embryos) could be screened in 1 day.

ChIP-sequencing {#s4-4}
---------------

ChIPs were performed with whole cell extracts (WCE) from embryos as previously described ([@bib63]) using 200 μl embryos for pre-MBT embryos and 50 μl for older embryos. Libraries from the immunoprecipitated DNA and WCE DNA were prepared using the Paired-End DNA Sample Preparation Kit (PE-102-1001; Illumina, San Diego, CA) but with a modified protocol. To remove adapter dimers, biotin-labeled dATP (19524-016; Invitrogen, Grand Island, NY) was added in the A-tailing reaction after end-repair. After ligation to the PE adaptor, the samples were incubated with streptavidin beads in 500 μl binding buffer (650-01; Invitrogen) at room temperature for 15 min. DNA bound to the beads was then washed twice with 800 μl binding buffer with 0.05% Tween 20, twice with NEB buffer 2 (New England Biolabs, Ipswich, MA) and resuspended in 31 μl NEB buffer 2. The PCR reaction was then performed according to the Illumina protocol.

Nucleosome mapping {#s4-5}
------------------

50 μl sorted 2--3 hr embryos were homogenized as previously described ([@bib63]) and digested based on a previously published protocol ([@bib37]). Briefly, homogenized chromatin in NPS buffer was digested with an MNase (LS004798; Worthington, Lakewood, NJ) gradient of 20 U, 10 U, 5 U, 5/2 U, 5/4 U, 5/8 U, 5/16 U, to 5/32 U, and a negative control for 30 min at 37°C. Mono-nucleosome size DNA was extracted from the lane with two clear bands in a 1.7% agarose gel, and prepared for paired-end sequencing.

Alignment of ChIP-seq and MNase-seq data {#s4-6}
----------------------------------------

All sequencing reads were aligned to the UCSC *Drosophila melanogaster* dm3 genome with Bowtie v0.12.8 ([@bib28]) using the following parameters:

-k 1 --m 1 --l 40 --n 2 --best --strata

The MBT MNase-seq library was paired-end sequenced and alignment was performed with an allowable insert size of 47 bp to 297 bp. After alignment, single-end reads were extended to the estimated insert size of the library as determined by a Bioanalyzer. To identify alignment and amplification artifacts, custom R scripts were used to analyze the aligned reads of all single-end libraries with more than 10 duplicates (defined as having the same chromosome, start and strand values). These 'stacks' of identical reads were removed unless a corresponding number of reads were present on the opposite strand approximately one fragment length away in the 3′ direction. For all libraries, genome-wide coverage was calculated by assigning an integer score to each genomic coordinate representing the number of extended reads that overlapped that location.

Analysis of RNA-seq expression data {#s4-7}
-----------------------------------

To obtain gene expression measurements at different nuclear cycles, we downloaded single-embryo RNA-seq datasets from <http://eisenlab.org/dosage/> ([@bib36]). One female and one male replicate were downloaded for nuclear cycles 10, 11, 12, 13 and 14 (A-D). The male and female datasets were combined for each nuclear cycle. In addition, we downloaded 4--6 hr and 6--8 hr staged whole-embryo RNA-seq datasets ([@bib19]). We processed all samples using TopHat v2.0.4 ([@bib58]) by aligning against the FlyBase r5.47 genome and its corresponding gene annotations using the following parameters:

Single-embryo samples (40 bp reads):

-G fb-r5.47.gtf --I 5000 --segment-length 20 fb547_genome

4--6 hr and 6--8 hr embryo samples (75 bp reads):

-G fb-r5.47.gtf--I 5000 --segment-length 37 fb547_genome

Next, we used the cuffdiff tool from Cufflinks v2.0.2 ([@bib59]) to obtain gene expression values (RPKMs) for all samples using the following non-default parameters:

-u --b fb547_genome.fa fb-r5.47.gtf

Calculating Pol II enrichments and stalling indexes {#s4-8}
---------------------------------------------------

For the four Pol II replicates in the pre-MBT embryo and the three Pol II replicates in the MBT embryo, enrichment ratios were calculated for the TSS region (first 200 bp of the transcript), a region immediately downstream of the TSS (+201 to +400 bp), and the transcription unit (TU) region (+401 to the end of the transcript) of each unique FlyBase r5.47 transcript. For transcripts less than 600 bp in length, the TU region was defined as the entire transcript. Total signal for each region was found for each Pol II and WCE sample. Enrichment in each region was calculated after normalizing for both fragment length and total read count:$$\text{Enrichment} = \left( {\text{IP~signal}/\left\lbrack {\text{IP~read~count} \times \text{IP~fragment~length}} \right\rbrack} \right)/\left( {\text{WCE~signal}/\left\lbrack {\text{WCE~read~count} \times \text{WCE~fragment~length}} \right\rbrack} \right)$$

The stalling index for each gene was defined as: log2 Pol II~TSS~--log2 Pol II~Downstream\ TSS~ after flooring both Pol II enrichment values at 1 (background). Stalling indexes for all replicates were averaged.

Identification and classification of pre-MBT genes {#s4-9}
--------------------------------------------------

To identify genes bound by Pol II in the pre-MBT embryo, we first identified all transcripts with Pol II~TSS~ enrichment twofold above WCE in all four replicates. To ensure that these enrichments were due to high Pol II signal, we also required the Pol II signal portion of the enrichment calculation (the numerator in the above equation) to be in the 99th percentile of all transcripts in all four replicates.

Manual inspection of some of these transcripts showed that the Pol II signal originated from a different gene's TSS (see examples in [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). To eliminate these false positives, we used MACS to identify peaks in our best pre-MBT TBP sample and manually examined all Pol II-enriched pre-MBT transcripts that did not have a detected TBP peak within 500 bp of the TSS. We used the default parameters of MACS v2.0.10.20120703 ([@bib65]), specifying only the preset alignable genome size for *Drosophila melanogaster* using the '-g dm' argument. This identified 12 transcripts in which the Pol II signal did not appear to originate from the TSS. These transcripts were removed from our pre-MBT list and are marked as 'rejected pre-MBT genes' in ([Supplementary file hosted by Dryad](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) \[7.6 Mb\]).

We next checked for possible pre-MBT genes with missing or mis-annotated transcription start sites. To do this, we used MACS to call peaks on all four of our pre-MBT Pol II samples using the same default parameters as described above. We then identified all regions that were called as peaks in at least two of the four replicates. These regions were assigned to the nearest gene within 5 kb and all regions assigned to a gene not already considered a pre-MBT gene were manually examined. This revealed ten possible additional pre-MBT genes where the Pol II signal originated from an un-annotated transcription start site. As all of these genes also had at least some TBP signal upstream of the Pol II signal, we defined custom transcript entries for these genes by setting the transcript start site to 19 bp downstream of the location of the maximum TBP signal. To ensure these custom transcripts met our existing enrichment criteria, we performed the same calculations as described above in the Calculating Pol II enrichments section. All ten of the custom transcripts were sufficiently enriched in Pol II and were added to our pre-MBT gene list.

We classified the 117 pre-MBT genes into three groups. First, the 'paused' group was defined as those pre-MBT genes having a mean (among all four replicates) Pol II~TU~ ratio less than 1. The 'dual' group was defined as any pre-MBT gene not in the paused group that had Pol II~TSS~ enrichment in the top 20% of all genes in 6--8 hr Mef2-positive muscle cells ([@bib17]). The remaining pre-MBT genes were classified as the 'not paused' group.

Identification and classification of MBT genes {#s4-10}
----------------------------------------------

To identify genes bound by Pol II in the MBT embryo, we selected all transcripts with Pol II~TSS~ enrichment at least twofold above WCE in all three replicates. If multiple transcripts for the same gene met these criteria, we selected the one with the highest Pol II~TSS~ signal (breaking ties using the mean Pol II~TU~ enrichment).

MBT genes were classified into three groups using gene expression values calculated from previously published single-embryo RNA-seq experiments (see 'Analysis of RNA-seq expression data' section). We classified as 'maternal' all MBT genes with an RPKM of at least 1 in nuclear cycle 10. We classified as 'MBT active' all non-maternal MBT genes with an RPKM of at least 5 in nuclear cycle 14D. The remaining MBT genes were classified as 'MBT paused'.

Conservation analysis {#s4-11}
---------------------

PhastCons scores ([@bib51]) from the alignment of 14 insect species' genome assemblies to the *Drosophila melanogaster* genome were downloaded from <http://hgdownload-test.cse.ucsc.edu/goldenPath/dm3/phastCons15way/>. For each mRNA transcript in Flybase r5.47, the mean phastCons score along the transcript's length was used as a relative measure of conservation. These transcripts were then organized into groups as described in the 'Identification and classification of pre-MBT genes' and 'Identification and classification of MBT genes' sections.

Normalization of reads and enrichment values {#s4-12}
--------------------------------------------

For [Figure 1C](#fig1){ref-type="fig"}, enrichment values were first calculated in a 100 bp sliding window across all samples. Replicates were combined by taking the minimum enrichment value at each base. Samples were then independently normalized by defining 'minimum' as an enrichment value of 1 (background) and 'maximum' as the 99th percentile enrichment value encountered among all displayed bases. As there was no significant ChIP enrichment in the pre-MBT H3K4me3 sample, it was normalized to the maximum enrichment value of the MBT H3K4me3 sample to avoid amplifying noise.

For [Figure 2](#fig2){ref-type="fig"}, [Figure 3C](#fig3){ref-type="fig"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, both read counts and enrichment values for each sample were independently scaled by dividing the values at each base by the maximum value encountered among the displayed genes or gene groups across stages after normalizing for both read count and fragment size differences.

Metapeak analysis for H3K27me3 ChIP-Seq {#s4-13}
---------------------------------------

Using supplemental Table 17 from Schuettengruber et al. ([@bib49]), the 441 regions were selected based on Ph ChIP-chip enrichment (p\<0.0001). The regions were then aligned at their midpoints and extended by 80 kb in both directions. Average region graphs were constructed showing the average enrichment value at each base for three H3K27me3 samples. The enrichment for each sample was defined by dividing read-count normalized IP signal by the read-count normalized WCE control signal.

Promoter element annotations {#s4-14}
----------------------------

Sequences surrounding all FlyBase r5.47 transcription start sites (plus our ten additional custom pre-MBT transcripts) were scanned for the core promoter elements listed in [Table 3](#tbl3){ref-type="table"}. A core promoter element was scored as present if found with no mismatch within a specified window relative to the transcription start site. For Zelda, we also counted the number of motifs found in each transcript's window.

Promoter element enrichments {#s4-15}
----------------------------

For each group of transcripts analyzed for promoter element composition, an enrichment and p-value were calculated for each promoter element. Enrichment was calculated as follows, where G is the group of transcripts tested and PE is a particular promoter element:$$\begin{array}{l}
{\text{Observed} = \left( \text{Number~of~transcripts~in~G~with~element~PE} \right)/\left( \text{Number~of~transcripts~in~G} \right)} \\
{\text{Expected} = \left( \text{Number~of~transcripts~in~the~genome~with~element~PE} \right)/\left( \text{Number~of~transcripts~in~the~genome} \right)} \\
{\text{Enrichment} = \text{Observed}/\text{Expected}} \\
\end{array}$$

For enrichment values less than one, the negative reciprocal of the enrichment value was used (indicating depletion instead of enrichment). To calculate a p-value for the observed frequency of each promoter element in each group of transcripts, a Fisher test was performed. Enrichments and depletions with a p\<0.05 (after correcting for multiple testing with the Benjamini and Hochberg method) were deemed significant.

For Zelda, we calculated enrichment and p-values via random sampling. Enrichment values for each group of transcripts were calculated by dividing the number of Zelda sites per transcript in each group by the average number of Zelda sites per transcript in the genome. To calculate p-values for each group of transcripts, we randomly selected an equal number of transcripts from the entire genome 10,000 times and calculated the enrichment value for each random sample. The p-value was then calculated as the portion of random samples with higher Zelda enrichment than the transcript group.

Promoter element co-occurrence analysis {#s4-16}
---------------------------------------

The enrichments (Observed/Expected) and p-values (Fisher test) for the co-occurrence of promoter elements were calculated for all pairs of core promoter elements in three sets of genes. For the 'FitzGerald' set of genes, we extracted the gene and overlap counts for a subset of motifs listed in [Table 1](#tbl1){ref-type="table"} of [@bib15]. For the 'all promoters' set, we included all unique promoters in FlyBase r5.47 as well as our additional ten custom transcripts. For the 'pre-MBT and MBT' set, we included only the promoters of our pre-MBT and MBT gene groups. The order of motifs shown in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} was determined by hierarchically clustering the enrichment values with the R v3.0.1 *hclust* function using Euclidean distance. For the Zelda motif, which can occur multiple times in a single promoter region, the presence of at least one motif within 2 kb upstream was scored.

De novo motif discovery {#s4-17}
-----------------------

Fasta sequence files were generated for each of the classified Pre-MBT and MBT groups, based on regions ±100 bp surrounding the FlyBase r5.47 transcription start sites (plus our ten additional custom pre-MBT transcripts). Using MEME v4.8.1 ([@bib5]) the fasta files were processed using the following parameters:

-mod zoops -dna -nmotifs 50 -revcomp -maxw 12 -maxsize 5000000 -oc meme/

The resulting motifs were then compared against the TRANSFAC 2011.4 database and the [Table 3](#tbl3){ref-type="table"} listed above using the TOMTOM tool also from the MEME suite.

ImaGO earliest annotated expression analysis {#s4-18}
--------------------------------------------

To calculate enrichment of gene groups for their first expression in specific tissues, we downloaded the Berkeley *Drosophila* Genome Project in situ expression database from <http://insitu.fruitfly.org/> ([@bib56], [@bib57]). We removed the 'maternal' and 'no staining' annotation entries and then removed all but the first (in stage order) annotation of each gene. For each gene group analyzed, we calculated enrichments and p-values using the same method as the promoter element enrichment analysis described above.

Analysis of gene expression over time {#s4-19}
-------------------------------------

For all gene groups plotted in [Figure 2B](#fig2){ref-type="fig"} and [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}, we first removed any genes with evidence of maternally deposited mRNA using the following criteria:RPKM expression \> 16 in nuclear cycle 10, orMaternal expression at least twofold above zygotic expression in nuclear cycle 10 \[F10 sample in Dataset S1 of S. E. Lott et al. ([@bib36])\]

Open access of data and analysis {#s4-20}
--------------------------------

All ChIP-seq and MNase-seq data have been deposited with the NCBI Gene Expression Omnibus under accession number [GSE41703](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41703). In addition, we have replicated our analysis environment (including software tools, analysis source code, and raw data) in a Linux virtual machine hosted by Amazon Web Services. Instructions for accessing the virtual machine can be found at <http://research.stowers.org/zeitlingerlab/data>. The analysis code is available on GitHub at <https://github.com/zeitlingerlab/chen_elife_2013>.

Supplementary spreadsheet {#s4-21}
-------------------------

A [spreadsheet](http://datadryad.org/bitstream/handle/10255/dryad.52325/supplemental_file_1.xlsx) summarizing our classification and analysis of pre-MBT and MBT gene groups is available via Dryad digital repository. The first sheet gives an explanation for all column headings. The second sheet lists all data for all our annotated genes, including our ten custom transcripts. It includes the classifications into pre-MBT and MBT gene groups, the Pol II ChIP-seq enrichment values at the transcription start site (TSS) and transcription unit (TU) for all replicates, phastCon conservation scores, and the presence or absence of all core promoter motifs analyzed in this study, as well as the presence of the TATA element identified by de novo motif analysis.
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Major dataset
-------------

The following datasets were generated:

ChenK, JohnstonJ, ShaoW, MeierS, StaberC, ZeitlingerJ, 2013,A global change in RNA Polymerase II pausing during the *Drosophila* midblastula transition,GSE41703;<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41703>,Publicly available at GEO (<http://www.ncbi.nlm.nih.gov/geo/>)

ChenK, JohnstonJ, ShaoW, MeierS, StaberC, ZeitlingerJ, 2013,Data from: A global change in RNA Polymerase II pausing during the *Drosophila* midblastula transition,10.5061/dryad.rv624;<http://dx.doi.org/10.5061/dryad.rv624>,The spreadsheet summarizing our classification and analysis of pre-MBT and MBT gene groups is publicly available at Dryad (<http://datadryad.org/>)

The following previously published datasets were used:

LottSE, EisenMB, 2011,Non-canonical compensation of zygotic X transcription in *Drosophila melanogaster* development revealed through single embryo RNA-Seq,GSE25180;<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25180>,Publicly available at GEO (<http://www.ncbi.nlm.nih.gov/geo/>)

modENCODE Project, 2011,Developmental Time Course poly(A)+ RNA Profiling in *D. melanogaster*,SRP001065;<http://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP001065>,Publicly available at the Sequence Read Archive (<http://www.ncbi.nlm.nih.gov/sra>).
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Thank you for sending your work entitled "A global change in RNA Polymerase II pausing during the *Drosophila* midblastula transition" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor, a Reviewing editor, and 2 reviewers. The Reviewing editor and reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

We are delighted to tell you that the review of your manuscript is now completed and the reviewers really liked your study. We suggest a few small changes that we are sure you can do in short time. Please below see the combined reviews.

This study constitutes an important systematic contribution to the analysis of the expression profile and chromatin state of the *Drosophila* embryo, before, during, and after the midblastula transition. Pre-MBT embryos were carefully hand-sorted and analyzed by ChIP-seq for Pol II, TBP, and histone modifications ([Figure 1](#fig1){ref-type="fig"}). Strong occupancy of TBP and Pol II as well as low levels of H3K4me3 were observed on the pre-MBT genes in the pre-MBT embryos ([Figure 1C](#fig1){ref-type="fig"}). By using a pausing index based on the distribution of Pol II, it was found that most (77 to 107 out of 117) pre-MBT genes exhibit little transcriptional pausing ([Figure 2](#fig2){ref-type="fig"}). In contrast, a strong extent of pausing was observed with genes that are activated during the MBT ([Figure 3](#fig3){ref-type="fig"}). H3K4me3 and H3K27me3 were essentially absent from the nuclei of pre-MBT embryos ([Figure 4](#fig4){ref-type="fig"}). Analysis of core promoter sequences revealed that the TATA box is significantly enriched in the promoters of pre-MBT genes ([Figure 5](#fig5){ref-type="fig"}). These findings lead to the model shown in [Figure 6](#fig6){ref-type="fig"}. In essence, zygotic transcription from pre-MBT genes appears to occur typically via the TATA box by a mechanism that does not involve transcriptional pausing.

The findings suggest that there is a specific, perhaps streamlined, mechanism of transcription involving the TATA box that is used to achieve the rapid synthesis of transcripts that is needed in the pre-MBT embryo. This is a notable and interesting finding.

Prior to publication we would like to see the following changes made to the manuscript. These changes are largely aimed at making the manuscript more easily accessible to the readership.

1\) The authors need to provide some statistics on reproducibility among the biological replicates used.

2\) While the authors will release a GEO accession, having supplements at the journal site is a good idea. Supplementary file 1 is critical (the most important for anyone really wanting to study the primary results), but is lacking in ways that will make it difficult to use. There should be another sheet in the workbook, or a separate readme file that has all the def lines and nomenclature explained. For example, I have no idea what "Custom_slam" means in a column where all the rest of the cells appear to have FBtr\#s. I can guess what most of the columns labels mean, but you should not make the reader do this. Additionally, many of the important data fields in Supplementary file 1 are conclusions rather than data (e.g., "yes", "never-paused", etc). These should be replaced with numbers used for the classification system as outlined in the methods. The classification scheme itself is somewhat ad hoc and in a different study, by a different lab, so it is almost certain that some of the same genes will be classified differently. These types of data handling issues have muddled many areas of genomics and can be ameliorated by giving others data, allowing them to apply a different classifier.

3\) Write something about the nucleosome positioning in [Figure 4C](#fig4){ref-type="fig"}.

4\) The core promoter enrichments are clear in [Figure 5A](#fig5){ref-type="fig"}, but are there any dependencies of the type mentioned in the Discussion? For example, in the case of preMBT dual genes, do they have an Inr and a PB element? One or the other?

5\) In [Figure 5B](#fig5){ref-type="fig"}, the locations of the putative DPE, MTE and PB sites are distributed throughout the promoter region. It is known, however, that these sequences function only in a specific downstream location. Therefore, DPE, MTE, and PB-like sequences that are not located in their characteristic downstream location should probably be disregarded.

6\) There are a confusing number of core promoter and MBT classification names. This is certainly not all the fault of the authors, but it would help the reader if the names from the traditional literature and the computational studies were both used or listed somewhere to help match Ohler and FitzGerald, for example. This could be added to the "promoter element table". The authors should not send the reader to another paper for a term that they could easily define in the manuscript (dispersed and focused are never described). The long descriptors ("pre-MBT not-paused genes") could be replaced in the figures with data in the heat maps. Almost anything that would make the high-dimensional naming of promoters easier to follow would be greatly appreciated.

10.7554/eLife.00861.019

Author response

*1) The authors need to provide some statistics on reproducibility among the biological replicates used*.

We agree that additional information about the reproducibility of our ChIP-seq experiments would be useful. In addition to the existing scatterplots comparing two replicates each of pre-MBT and MBT Pol II~TSS~ enrichments in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}, we have calculated Pearson correlations for the four pre-MBT Pol II replicates and the three MBT Pol II replicates. The correlations are all very high, ranging from 0.78 to 0.92 for the pre-MBT replicates and from 0.96 to 0.98 for the MBT replicates, in comparison to 0.16 to 0.33 when these replicates are correlated with input (WCE). They are now shown in panel B of [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}.

*2) While the authors will release a GEO accession, having supplements at the journal site is a good idea. Supplementary file 1 is critical (the most important for anyone really wanting to study the primary results), but is lacking in ways that will make it difficult to use. There should be another sheet in the workbook, or a separate readme file that has all the def lines and nomenclature explained. For example, I have no idea what "Custom_slam" means in a column where all the rest of the cells appear to have FBtr\#s. I can guess what most of the columns labels mean, but you should not make the reader do this. Additionally, many of the important data fields in Supplementary file 1 are conclusions rather than data (e.g., "yes", "never-paused", etc). These should be replaced with numbers used for the classification system as outlined in the methods. The classification scheme itself is somewhat ad hoc and in a different study, by a different lab, so it is almost certain that some of the same genes will be classified differently. These types of data handling issues have muddled many areas of genomics and can be ameliorated by giving others data, allowing them to apply a different classifier*.

We apologize for the lack of full descriptions in the spreadsheet and we have substantially revised it to improve its clarity and usefulness. As suggested, we have added an additional sheet containing complete descriptions of each column. In addition, we have added all data columns used in our gene classification schemes.

*3) Write something about the nucleosome positioning in* [*Figure 4C*](#fig4){ref-type="fig"}.

We now say in the legend of [Figure 4C](#fig4){ref-type="fig"}: "The overall nucleosome occupancy, as measured by MNase digestion, shows more pronounced nucleosome positioning at MBT maternal genes but the overall nucleosome occupancy is not dramatically different (compare top and bottom panels at the right)."

We did not emphasize this result in the main text because the strong positioning of nucleosomes at promoters with dispersed initiation has been observed before ([@bib44] and [@bib17]) and the number of pre-MBT genes is relatively small.

*4) The core promoter enrichments are clear in* [*Figure 5A*](#fig5){ref-type="fig"}*, but are there any dependencies of the type mentioned in the Discussion? For example, in the case of preMBT dual genes, do they have an Inr and a PB element? One or the other*?

Thank you for the suggestion. We have now added a figure on the co-occurrence of promoter elements ([Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}). Our results agree very well with previous results ([@bib15]) and show that the association between Zelda, TATA, and Inr is specific for early development.

We have added this analysis and mention this result in the main text: "Finally, an analysis of the co-occurrences of core promoter elements similar to previous analyses ([@bib15]) also supports our finding ([Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}). For example, Zelda, Inr, and TATA significantly co-occur among all our Pol II-bound genes (pre-MBT and MBT genes) but not among all annotated genes, suggesting that these motifs preferentially function together during early development."

The figure also shows that Inr and PB significantly co-occur. Note, however, that most co-occurrences are only significant when analyzing a large data set and not in selected pre-MBT or MBT gene sets. Thus, it is likely that promoters do not generally require a pair of motifs with a perfect match to the consensus sequence (i.e., a high affinity binding site). We interpret a co-occurrence of two motifs as evidence that they are found in the same promoter type and can function together.

*5) In* [*Figure 5B*](#fig5){ref-type="fig"}*, the locations of the putative DPE, MTE and PB sites are distributed throughout the promoter region. It is known, however, that these sequences function only in a specific downstream location. Therefore, DPE, MTE and PB-like sequences that are not located in their characteristic downstream location should probably be disregarded*.

We agree that instances of DPE, MTE and PB motifs found upstream of the transcription start site in the MBT active gene group are unlikely to be functional. That's why we selected a specific window relative to the transcription start site when we scanned for known motif sequences in [Figure 5A](#fig5){ref-type="fig"}. These windows are listed in the promoter element table in the methods and were based on previous experimental evidence and our own computational analyses. In contrast, [Figure 5B](#fig5){ref-type="fig"} shows a de novo motif analysis and the distribution for each recovered known motif. This shows that the most frequent location of the identified motifs agrees with previous studies. Although the recovered DPE/MTE/PB motif is not as specific in its location, we felt that it would be wrong to manipulate the original results. Rather, our results suggest that the recovered DPE/MTE/PB motif is more frequently found by chance (outside its location where it is functional) as compared to the other motifs.

We apologize for the confusion this has caused and added to the legend of [Figure 5A](#fig5){ref-type="fig"}. "Only occurrences close to the known location of the motif relative to the TSS were scored (see promoter element table in the Materials and methods)." Furthermore, we added to the legend of [Figure 5B](#fig5){ref-type="fig"}: "Note that all motifs are found with the highest frequency at the expected location, but that the DPE/MTE/PB motif is less specific and more frequently found at positions where it is unlikely to be functional as a core promoter element."

*6) There are a confusing number of core promoter and MBT classification names. This is certainly not all the fault of the authors, but it would help the reader if the names from the traditional literature and the computational studies were both used or listed somewhere to help match Ohler and FitzGerald, for example. This could be added to the "promoter element table". The authors should not send the reader to another paper for a term that they could easily define in the manuscript (dispersed and focused are never described). The long descriptors ("pre-MBT not-paused genes") could be replaced in the figures with data in the heat maps. Almost anything that would make the high-dimensional naming of promoters easier to follow would be greatly appreciated*.

We also noticed that promoter studies and their classifications are not well known to a general audience. We have therefore now defined focused and dispersed promoters in the text, and mention their alternative names (peaked and broad promoters):

"Focused transcription initiates within a very narrow window and often at a single nucleotide (also called peaked promoters), while dispersed transcription initiates from several weak transcription start sites within a ∼150 nucleotide region (also called broad promoters). In *Drosophila*, dispersed initiation is typically found at broadly expressed housekeeping genes with constitutive promoters."

We also evaluated whether we could simplify our nomenclature but only found one instance where it was not completely consistent. We had labeled the Ohler motifs as either Motif1, etc. or Ohler1, etc. We have now consistently referred to these motifs as Ohler1, etc. to make sure the source is clear (for example, as opposed to the FitzGerald nomenclature). Overall, we feel that our choice, description, and presentation of the core promoter elements is systematic:

• We only include core promoter elements in the analysis that are relatively well understood to avoid confusion.

• We are always using traditional names if available (DPE, DRE, GAGA, Inr, MTE, PB, TATA, Zelda) and use the Ohler nomenclature only if no other name is known (Ohler1, Ohler6, Ohler7).

• If possible, we always mention promoter elements that belong to the same promoter type together.

• In the figures, core promoter elements are sorted and grouped by function for clarity.

[^1]: Bold marks the pre-MBT dual genes and italic marks the pre-MBT paused genes.

[^2]: Mann--Whitney test for pre-MBT vs MBT zygotic transcript size: p\<10^−20^.

[^3]: Fisher test for pre-MBT vs MBT zygotic: p\<0.0003.

[^4]: Fisher test for pre-MBT vs MBT zygotic: p\<10^−23^.
